Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SpainBack to Spain

Clinical trials in Esplugues de Llobregat, Barcelona

2 clinical trials in Esplugues de Llobregat, Barcelona, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Esplugues de Llobregat, Barcelona at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Esplugues de Llobregat, Barcelona

Open in trial search

Contraception+1

Recruiting

Contraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Drospirenone
  • Sponsor:Chemo Research S.L.

Infertility male

Recruiting

Study of vaginal pentoxifylline gel PKB171 compared to placebo in couples with mild male infertility due to low sperm count or poor sperm movement

Investigational
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Pentoxifylline
  • Sponsor:Prokrea Bcn S.L.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Esplugues de Llobregat, Barcelona

What the registry says about research in the country

01 Male Factor Infertility Research

A study conducted in Esplugues de Llobregat evaluates a post‑coital intravaginal gel intended to improve clinical pregnancy rates for couples facing mild male factor infertility.

  • Clinical pregnancy outcomes
  • Mild male factor infertility
  • Intravaginal gel therapy
  • Treatment cycle efficacy

The trial seeks to determine if the gel can increase the likelihood of a confirmed intrauterine pregnancy by weeks 6‑8 of gestation.

02 Contraceptive Efficacy Studies

Researchers in Esplugues de Llobregat are assessing a new contraceptive gel that combines drospirenone with a low‑dose hormonal component to provide reliable birth control over multiple cycles.

  • Contraceptive efficacy
  • Safety and tolerability
  • Multi‑cycle use
  • Hormonal drospirenone formulation

This open‑label, single‑arm trial aims to verify consistent contraceptive performance across 13 menstrual cycles while monitoring adverse events.

Back to SpainAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.